These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39069228)

  • 1. Evolutionary adaptation of KPC-2-producing Pseudomonas aeruginosa high-risk sequence type 463 in a lung transplant patient.
    Zhang P; Hu J; Wu W; Shi W; Jiang Y; Yu Y; Zheng X; Qu T
    Int J Antimicrob Agents; 2024 Sep; 64(3):107279. PubMed ID: 39069228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain.
    Tu Y; Wang D; Zhu Y; Li J; Jiang Y; Wu W; Li X; Zhou H
    Microbiol Spectr; 2022 Feb; 10(1):e0186921. PubMed ID: 35019766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance.
    Tang C; Shen S; Yang W; Shi Q; Ding L; Han R; Yin D; Guo Y; Zhu D; Hu F
    Int J Antimicrob Agents; 2024 Sep; 64(3):107265. PubMed ID: 38964622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing
    Soto KD; Alcalde-Rico M; Ugalde JA; Olivares-Pacheco J; Quiroz V; Brito B; Rivas LM; Munita JM; García PC; Wozniak A
    Front Cell Infect Microbiol; 2024; 14():1410834. PubMed ID: 38903939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection.
    Khil PP; Dulanto Chiang A; Ho J; Youn JH; Lemon JK; Gea-Banacloche J; Frank KM; Parta M; Bonomo RA; Dekker JP
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to ceftazidime-avibactam and other new β-lactams in
    Valzano F; La Bella G; Lopizzo T; Curci A; Lupo L; Morelli E; Mosca A; Marangi M; Melfitano R; Rollo T; De Nittis R; Arena F
    Microbiol Spectr; 2024 Aug; 12(8):e0426623. PubMed ID: 38934607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.
    Zhang Y; Zhao J; Han J; Fan Y; Xiong Z; Zou X; Li B; Liu X; Li Z; Lu B; Cao B
    Microbiol Spectr; 2022 Apr; 10(2):e0274021. PubMed ID: 35315696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of
    Li X; Zhou L; Lei T; Zhang X; Yao J; He J; Liu H; Cai H; Ji J; Zhu Y; Tu Y; Yu Y; Zhou H
    Emerg Microbes Infect; 2024 Dec; 13(1):2324068. PubMed ID: 38406830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent
    Shi Q; Shen S; Tang C; Ding L; Guo Y; Yang Y; Wu S; Han R; Yin D; Hu F
    Emerg Microbes Infect; 2024 Dec; 13(1):2361007. PubMed ID: 38801099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double
    Hu D; Wang S; Xu M; Zhang J; Luo X; Zhou W; Ma Q; Ma X
    Microbiol Spectr; 2024 Aug; 12(8):e0033124. PubMed ID: 38984824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of
    Wang L; Zhang X; Zhou X; Yang F; Guo Q; Wang M
    Microbiol Spectr; 2023 Jun; 11(3):e0093223. PubMed ID: 37199669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime-Avibactam Resistance Associated with Increased
    Coppi M; Di Pilato V; Monaco F; Giani T; Conaldi PG; Rossolini GM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and bla
    Tang C; Shen S; Yang W; Shi Q; Ding L; Han R; Hu F
    Int J Antimicrob Agents; 2024 Aug; 64(2):107228. PubMed ID: 38823494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of resistance to ceftazidime-avibactam during infection treatment in
    García P; Brito B; Alcalde-Rico M; Munita JM; Martínez JRW; Olivares-Pacheco J; Quiroz V; Wozniak A
    Front Cell Infect Microbiol; 2022; 12():981792. PubMed ID: 36118031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.
    Schaumburg F; Bletz S; Mellmann A; Becker K; Idelevich EA
    Int J Antimicrob Agents; 2019 Aug; 54(2):255-260. PubMed ID: 31071465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae.
    Zhang P; Hu H; Shi Q; Sun L; Wu X; Hua X; McNally A; Jiang Y; Yu Y; Du X
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0127922. PubMed ID: 36794957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate.
    Yang Q; Li Y; Fang L; Lei T; Cai H; Hua X; Zheng M; Yu Y
    Clin Microbiol Infect; 2023 Mar; 29(3):387.e7-387.e14. PubMed ID: 36252790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy.
    Piazza A; Mattioni Marchetti V; Bielli A; Biffignandi GB; Piscopiello F; Giudici R; Tartaglione L; Merli M; Vismara C; Migliavacca R
    J Microbiol Immunol Infect; 2024 Jun; 57(3):457-469. PubMed ID: 38584042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.